Loading...

PE anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_PE_122007
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE
  • BM8_PE_122007
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
123109 25 µg 35€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123110 100 µg 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hasan Z, et al. 2013. Am J Physiol Lung Cell Mol Physiol. 304:221. PubMed
  2. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  3. Peterson T, et al. 2016. Proc Natl Acad Sci U S A. 113: 4470-4475. PubMed
  4. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  5. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  6. Morris CR, et al. 2022. Mucosal Immunol. 15:977. PubMed
  7. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  8. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  9. Huang Q, et al. 2023. Immun Inflamm Dis. 11:e779. PubMed
  10. Li L, et al. 2023. iScience. 26:106095. PubMed
  11. Zhang X, et al. 2023. Heliyon. 9:e13490. PubMed
  12. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  13. Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed
  14. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  15. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  16. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  17. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  18. Chen S, et al. 2023. J Immunother Cancer. 11:. PubMed
  19. Duan JL, et al. 2023. Nat Aging. 3:258. PubMed
  20. Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed
  21. Yang Y, et al. 2023. Diagnostics (Basel). 13:. PubMed
  22. Tang M, et al. 2023. Sci Adv. 9:eade6624. PubMed
  23. Peng, P., Fan, S., et al. 2025. Mater Today Bio. 35(0),102601. PubMed
  24. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  25. Tan T, et al. 2019. Nat Commun. 10:3322. PubMed
  26. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  27. Zhao Y, et al. 2019. Mucosal Immunol. 1.298611111. PubMed
  28. Wang Q, et al. 2019. FASEB Bioadv. 1:609. PubMed
  29. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  30. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  31. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  32. Qin YY, et al. 2022. Mol Ther. 30:881. PubMed
  33. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  34. Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed
  35. Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed
  36. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  37. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  38. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  39. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  40. Pan L, et al. 2022. Mol Immunol. 147:101. PubMed
  41. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  42. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  43. Campisi L, et al. 2022. Nature. 606:945. PubMed
  44. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  45. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  46. Liu M, et al. 2022. Cells. 11: . PubMed
  47. Wang Y, et al. 2022. Cell Rep. 41:111738. PubMed
  48. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  49. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  50. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  51. Glaubitz J, et al. 2023. Gut. :. PubMed
  52. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  53. Zhang K, et al. 2023. Nat Metab. 5:129. PubMed
  54. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  55. Hattori Y, et al. 2023. Cell Rep. 42:112092. PubMed
  56. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  57. Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed
  58. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  59. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  60. Huang J, et al. 2021. Immunity. 54(4):673-686.e4. PubMed
  61. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  62. Karki R, et al. 2016. Nature. 10.1038/nature20597. PubMed
  63. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  64. Kloepper J, et al. 2016. Proc Natl Acad Sci U S A. 113: 4476-4481. PubMed
  65. O'Donnell C, et al. 2015. Br J Cancer. 114: 37 - 43. PubMed
  66. Maltby S, et al. 2014. J Immunol. 193:4072. PubMed
  67. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  68. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  69. Wietecha MS, et al. 2020. Nat Commun. 2.266666667. PubMed
  70. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  71. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  72. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  73. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  74. Yildirim Z, et al. 2022. EMBO Mol Med. 14:e15344. PubMed
  75. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  76. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  77. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  78. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  79. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  80. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  81. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  82. Yu S, et al. 2016. J Immunol. 197: 256 - 265. PubMed
  83. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  84. Guo HX, et al. 2018. World J Gastroenterol. 24:1779. PubMed
  85. Karki R et al. 2018. Cell. 173(4):920-933 . PubMed
  86. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  87. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  88. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  89. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  90. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  91. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  92. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  93. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  94. Matsushita Y, et al. 2021. J Bone Miner Res. 36:1145. PubMed
  95. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  96. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  97. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  98. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  99. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  100. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  101. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  102. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  103. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  104. Li T, et al. 2016. Cell Death Dis. 7:e2258. PubMed
  105. Elbaz M, et al. 2015. Mol Oncol. 9: 906-919. PubMed
  106. Tang E, et al. 2015. J Lipid Res. 56:358. PubMed
  107. Harel M, et al. 2020. Cell. 179(1):236-250.e18.. PubMed
  108. Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
  109. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  110. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  111. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  112. Truax AD et al. 2018. Cell host & microbe. 24(3):364-378 . PubMed
  113. Rashid K, et al. 2018. Sci Rep. 8:9023. PubMed
  114. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  115. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  116. Gopinathan G, et al. 2022. Mol Cancer Ther. 21:1030. PubMed
  117. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  118. Yu X, et al. 2021. Nature. 594:560. PubMed
  119. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  120. Liu Z, et al. 2015. Biol Reprod. 92:63. PubMed
  121. Nasser MW, et al. 2015. Cancer Res . 75: 974-985. PubMed
  122. Liu Y, et al. 2015. Sci Rep. 5:17215. PubMed
  123. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  124. Tencati M, Tapping R 2016. Infect Immun . 84: 2904 - 2913. PubMed
  125. Liao Y, et al. 2017. Virol J. 10.1186/s12985-017-0801-x. PubMed
  126. Dong G, et al. 2017. Biochim Biophys Acta. 10.1016/j.bbadis.2017.08.005. PubMed
  127. Tamura R, et al. 2017. Inflamm Regen. 36:26:00. PubMed
  128. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  129. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  130. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  131. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  132. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  133. Dignum T, et al. 2021. Cell Rep. 36:109675. PubMed
  134. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  135. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  136. Nabeta HW, et al. 2022. Front Cell Infect Microbiol. 12:976033. PubMed
  137. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  138. Kovacs L, et al. 2020. PLoS One. 15:e0240455. PubMed
  139. Oghumu S, et al. 2014. Immunology. 143: 109-119. PubMed
  140. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  141. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  142. Markov SD, et al. 2021. Mol Cancer Ther. 20:2457. PubMed
  143. Sun P, et al. 2021. J Invest Dermatol. 141:1542. PubMed
  144. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  145. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  146. Glass A, et al. 2013. J Immunol. 190:4830. PubMed
  147. Izquierdo-Useros N, et al. 2014. J Immunol . 192:4852-4858. PubMed
  148. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  149. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  150. Cheng XS, et al. 2020. J Cell Mol Med. 24:8391. PubMed
  151. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  152. Lumbroso D, et al. 2018. Front Immunol. 9:358. PubMed
  153. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  154. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  155. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  156. Wu X, et al. 2021. Elife. 10:. PubMed
  157. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  158. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  159. Wang Q, et al. 2020. Res Sq. . PubMed
  160. Hofbauer D, et al. 2021. Immunity. 54(8):1772-1787.e9. PubMed
  161. Lin J, et al. 2017. Sci Rep. 7:41722. PubMed
  162. Yin T, et al. 2016. Sci Rep. 18:19534. PubMed
  163. Mitsuhashi A, et al. 2015. Nat Commun. 6: 8792. PubMed
  164. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  165. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  166. Das LM, et al. 2019. Autophagy. 15:813. PubMed
  167. Pelka K, et al. 2018. Immunity. 48:911. PubMed
  168. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  169. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  170. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  171. Ma K, et al. 2021. J Leukoc Biol. 110:927. PubMed
  172. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  173. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  174. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  175. Wang H, et al. 2021. Malar J. 20:249. PubMed
  176. Chen W, et al. 2016. J Immunol. 197: 3554 - 3565. PubMed
  177. Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed
  178. Li N, et al. 2021. eLife. 10:00. PubMed
  179. Penninger P, et al. 2021. STAR Protocols. 2(1):100352. PubMed
  180. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  181. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  182. Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
  183. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  184. Iizasa E, et al. 2021. Nat Commun. 12:2299. PubMed
  185. Hu M, et al. 2021. J Clin Invest. 131:. PubMed
  186. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  187. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  188. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  189. Kuai Y, et al. 2020. Theranostics. 5.099305556. PubMed
  190. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  191. Wang C, et al. 2017. J Ethnopharmacol. 10.1016/j.jep.2017.06.014. PubMed
  192. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  193. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  194. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  195. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  196. McDonald B, et al. 2020. Cell Host Microbe. 28(5):660-668.e4. PubMed
  197. Devi S, et al. 2021. Immunity. 54(6):1219-1230.e7. PubMed
  198. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  199. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  200. Michaud J, et al. 2017. BMC Microbiology . 10.1186/s12866-017-1036-0. PubMed
  201. Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed
  202. Sun T, et al. 2017. Mucosal Immunol. 0.954861111. PubMed
  203. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  204. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  205. Bai B, et al. 2021. Theranostics. 11:6225. PubMed
  206. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  207. Cho K, et al. 2021. iScience. 24:103117. PubMed
  208. Ma S, et al. 2022. Cell Rep. 38:110520. PubMed
  209. Sharma S, et al. 2021. Pathophysiology. 28:501. PubMed
  210. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  211. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  212. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  213. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  214. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  215. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  216. Pashover-Schallinger E, et al. 2012. FASEB J. 26:3891. PubMed
  217. Min C, et al. 2020. Cell Death Dis. 0.847916667. PubMed
  218. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  219. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  220. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  221. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  222. Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
  223. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  224. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  225. Fields L, et al. 2021. Mol Ther. 29:2554. PubMed
  226. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  227. Murr NJ, et al. 2021. Nutrients. 13:. PubMed
  228. Zhang S, et al. 2014. Eur J Pharmacol. 733:45. PubMed
  229. Kumagai S, et al. 2016. Cardiovasc Res. 109: 272 - 282. PubMed
  230. Ikezoe K, et al. 2016. Sci Rep. 6: 25781. PubMed
  231. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  232. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  233. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  234. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  235. Li B, et al. 2019. Oncol Rep. 41:608. PubMed
  236. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  237. Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
  238. Kolodkin-Gal D, et al. 2021. Gut. Online ahead of print. PubMed
  239. Fu Y, et al. 2021. Front Cell Dev Biol. 9:689727. PubMed
  240. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
  241. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  242. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  243. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  244. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  245. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  246. Yahuafai J, et al. 2014. J Control Release. 28:192. PubMed
  247. Sun X, et al. 2020. Cell Metabolism. 31(1):189-206.e8.. PubMed
  248. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  249. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  250. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  251. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  252. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  253. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  254. Lamb T, et al. 2022. Toxics. 10:. PubMed
  255. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  256. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  257. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  258. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  259. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  260. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  261. Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed
  262. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  263. Yang H, et al. 2020. Arterioscler Thromb Vasc Biol. 40:e350. PubMed
  264. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  265. Sundar I, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.09.157. PubMed
  266. Maniati E, et al. 2020. Cell Rep. 30:525. PubMed
  267. Han MS, et al. 2020. Proc Natl Acad Sci U S A. 117:2751. PubMed
  268. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  269. Kang M, et al. 2021. Front Cell Dev Biol. 8:596622. PubMed
  270. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  271. Wang S, et al. 2022. J Inflamm Res. 14:7107. PubMed
  272. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  273. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  274. Valkenburg S, et al. 2016. Sci Rep. 6:22666. PubMed
  275. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  276. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  277. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  278. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  279. William M, et al. 2018. J Immunol. 200:4102. PubMed
  280. Ayturk UM, et al. 2020. J Bone Miner Res. 35:1981. PubMed
  281. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  282. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  283. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  284. Gao X, et al. 2021. Nature. 589:591. PubMed
  285. Lee SA, et al. 2021. Cells. 10:. PubMed
  286. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  287. Xiang Y, et al. 2014. Proc Natl Acad Sci U S A. . PubMed
  288. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  289. Peng X, et al. 2015. J Immunol. 195: 2797-2805. PubMed
  290. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  291. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  292. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  293. Silva-Cayetano A, et al. 2020. Med. 2(3):243-262.e8. PubMed
  294. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  295. Zhang J, et al. 2018. Oncoimmunology. 7:e1461301. PubMed
  296. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  297. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  298. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  299. Xu M, et al. 2020. Cell. 178(6):1478-1492.e20.. PubMed
  300. Wang Q, et al. 2020. Respir Res. 0.981944444. PubMed
  301. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  302. Zhang F, et al. 2021. J Immunol Res. 2021:5521051. PubMed
  303. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  304. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  305. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  306. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  307. Nakayama Y, et al. 2020. Proc Natl Acad Sci U S A. 117:14365. PubMed
  308. Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed
  309. Yin T, et al. 2015. J Immunol. 194:429. PubMed
  310. Zhang J, et al. 2014. J Immunol. 193:5149. PubMed
  311. Baker GJ, et al. 2020. Cell Syst. 0.647222222. PubMed
  312. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  313. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  314. Perrotta C, et al. 2018. Front Immunol. 9:1186. PubMed
  315. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  316. Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed
  317. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  318. Horwitz E, et al. 2014. Cancer Discovery. 4:730. PubMed
  319. Wang Y, et al. 2015. Sci Rep. 5:16973. PubMed
  320. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  321. Wang X, et al. 2020. Immunity. 328:52. PubMed
  322. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  323. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  324. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  325. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  326. Jiang M, et al. 2021. Front Pharmacol. 12:657486. PubMed
  327. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  328. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  329. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  330. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  331. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  332. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  333. Xiao M, et al. 2022. Mol Oncol. 16:1026. PubMed
  334. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  335. Gawish R, et al. 2022. Elife. 11:. PubMed
  336. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  337. Feng L, et al. 2014. Biochem Pharmacol. 89:109. PubMed
  338. Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed
  339. Samir P, et al. 2019. Nature. 573:590. PubMed
  340. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  341. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  342. Han J, et al. 2022. Cell Discov. 8:122. PubMed
  343. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  344. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  345. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  346. Witas R, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_893498 (BioLegend Cat. No. 123109)
AB_893486 (BioLegend Cat. No. 123110)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark Red™ 718 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Spark Blue™ 574 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
PE/Fire™ 640 anti-mouse F4/80 BM8 FC
PerCP/Fire™ 806 anti-mouse F4/80 BM8 FC
Go To Top Version: 2    Revision Date: 10/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account